Literature DB >> 9498772

Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.

D R Shafren1, D J Dorahy, R F Thorne, T Kinoshita, R D Barry, G F Burns.   

Abstract

Decay-accelerating factor (DAF), a widely expressed membrane complement-regulatory protein, is utilized as a cellular receptor by many human enteric pathogens. We show here that the binding of two enteroviruses to individual short consensus repeats (SCR) of DAF on the cell surface is greatly augmented by mAb binding to an alternate SCR: Coxsackievirus A21 binding to the SCR1 of DAF is increased by Ab binding to SCR3 and, conversely, Echovirus 7 binding to SCR3 is enhanced severalfold by Ab binding to SCR1. These Ab-induced increases in viral binding also resulted in increased viral infectivity. Using purified soluble DAF in a solid phase assay it was found that Ab binding to SCR1 is increased greatly in the presence of an Ab against SCR3 and, reciprocally, Ab against SCR1 greatly increases Ab binding to SCR3. In contrast to the results obtained with the larger viral particles, however, this reciprocal Ab-induced enhancement of binding is not seen when measuring Ab binding to membrane-bound DAF SCR on the cell surface. These findings provide a possible explanation for functional differences between membrane-bound and soluble DAF with implications for a potential role for DAF-binding molecules in regulating DAF function. This is the first demonstration of enhancement of viral infectivity mediated by Ab against the viral receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498772

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2.

Authors:  D R Shafren; J Gardner; V H Mann; T M Antalis; A Suhrbier
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.

Authors:  E Susanne Johansson; Li Xing; R Holland Cheng; Darren R Shafren
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity.

Authors:  Nicole G Newcombe; Leone G Beagley; Dale Christiansen; Bruce E Loveland; E Susanne Johansson; Ken W Beagley; Richard D Barry; Darren R Shafren
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.

Authors:  Nicole G Newcombe; E Susanne Johansson; Gough Au; A Michael Lindberg; Richard D Barry; Darren R Shafren
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation.

Authors:  Rafia J Hasan; Edyta Pawelczyk; Petri T Urvil; Mathura S Venkatarajan; Pawel Goluszko; Jozef Kur; Rangaraj Selvarangan; Stella Nowicki; Werner A Braun; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Viral cell entry induced by cross-linked decay-accelerating factor.

Authors:  D R Shafren
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.

Authors:  Amanda D Stuart; Hannah E Eustace; Thomas A McKee; T D K Brown
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.